DENTSPLY SIRONA Inc. (NASDAQ:XRAY) to Issue $0.16 Quarterly Dividend

DENTSPLY SIRONA Inc. (NASDAQ:XRAY) declared a quarterly dividend on Thursday, February 27th, RTT News reports. Investors of record on Friday, March 28th will be given a dividend of 0.16 per share by the medical instruments supplier on Friday, April 11th. This represents a $0.64 annualized dividend and a dividend yield of 3.40%.

DENTSPLY SIRONA has raised its dividend by an average of 14.2% annually over the last three years and has raised its dividend every year for the last 13 years. DENTSPLY SIRONA has a payout ratio of 29.8% meaning its dividend is sufficiently covered by earnings. Equities research analysts expect DENTSPLY SIRONA to earn $1.90 per share next year, which means the company should continue to be able to cover its $0.64 annual dividend with an expected future payout ratio of 33.7%.

DENTSPLY SIRONA Price Performance

XRAY stock opened at $18.81 on Thursday. The firm has a 50 day simple moving average of $18.90 and a two-hundred day simple moving average of $21.58. The stock has a market cap of $3.74 billion, a PE ratio of -9.09, a P/E/G ratio of 1.80 and a beta of 0.96. DENTSPLY SIRONA has a one year low of $17.21 and a one year high of $34.91. The company has a debt-to-equity ratio of 0.72, a current ratio of 1.25 and a quick ratio of 0.84.

DENTSPLY SIRONA (NASDAQ:XRAY) last released its earnings results on Thursday, February 27th. The medical instruments supplier reported $0.26 EPS for the quarter, missing analysts’ consensus estimates of $0.47 by ($0.21). DENTSPLY SIRONA had a negative net margin of 10.59% and a positive return on equity of 12.62%. On average, analysts predict that DENTSPLY SIRONA will post 1.84 EPS for the current fiscal year.

Wall Street Analyst Weigh In

A number of brokerages recently commented on XRAY. Jefferies Financial Group cut shares of DENTSPLY SIRONA from a “buy” rating to a “hold” rating and decreased their target price for the stock from $30.00 to $20.00 in a research report on Thursday, January 23rd. Morgan Stanley reduced their price target on DENTSPLY SIRONA from $30.00 to $23.00 and set an “overweight” rating on the stock in a research report on Tuesday, December 17th. Evercore ISI reiterated an “in-line” rating and issued a $20.00 price objective on shares of DENTSPLY SIRONA in a research report on Tuesday, January 7th. Needham & Company LLC reissued a “buy” rating and set a $25.00 price objective on shares of DENTSPLY SIRONA in a research note on Tuesday, February 11th. Finally, Leerink Partners downgraded shares of DENTSPLY SIRONA from an “outperform” rating to a “market perform” rating in a research note on Thursday, November 7th. Ten equities research analysts have rated the stock with a hold rating and five have issued a buy rating to the company. According to data from MarketBeat, DENTSPLY SIRONA has a consensus rating of “Hold” and an average target price of $24.50.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.